You are here

Treatments

After the USG stops buying the shots, Pfizer says COVID-19 vaccine will cost $110-$130 per dose

Fri, 2022-10-21 13:15 — mike kraft

Pfizer says COVID-19 vaccine will cost $110-$130 per dose Pfizer will charge $110 to $130 for a dose of its COVID-19 vaccine once the U.S. government stops buying the shots, but the drugmaker says it expects many people will continue receiving it for free. AP NEWS

...

Pfizer executives said the commercial pricing for adult doses could start early next year, depending on when the government phases out its program of buying and distributing the shots.

Country / Region Tags:

General Topic Tags:

Disease Prevention

Problem, Solution, SitRep, or ?:

Situation Report

Read more about After the USG stops buying the shots, Pfizer says COVID-19 vaccine will cost $110-$130 per dose
Log in or register to post comments

FDA’s vaccines chief sees possibility of more Covid boosters to iprove protection

Fri, 2022-10-21 10:17 — mike kraft

FDA’s vaccines chief sees possibility of more Covid boosters — sooner than he’d like The FDA’s vaccines chief sees the possibility of more Covid boosters for some people before next fall. Helen Branswell STAT

...

Country / Region Tags:

General Topic Tags:

Disease Prevention

Problem, Solution, SitRep, or ?:

Situation Report

Read more about FDA’s vaccines chief sees possibility of more Covid boosters to iprove protection
Log in or register to post comments

U.S. panel votes to add COVID shots to recommended vaccinations

Thu, 2022-10-20 16:42 — mike kraft

Panel votes to add COVID shots to recommended vaccinations NEW YORK (AP) — COVID-19 shots should be added to the lists of recommended vaccinations for kids and adults, a panel of U.S. vaccine experts said Thursday. The panel's unanimous decision has no immediate effect — COVID-19 shots already are recommended for virtually all Americans. AP NEWS

...

Country / Region Tags:

General Topic Tags:

Medical Personnel

Problem, Solution, SitRep, or ?:

Situation Report

Read more about U.S. panel votes to add COVID shots to recommended vaccinations
Log in or register to post comments

Moderna COVID vaccine safe, comparably effective in preschoolers ---clinical trial

Thu, 2022-10-20 16:35 — mike kraft

Study: Moderna COVID vaccine safe, comparably effective in preschoolers The vaccine in kids 6 months to 5 years triggered similar immune response and protection as in young adults. CIDRAP

Country / Region Tags:

General Topic Tags:

Disease Prevention

Medical Testing

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Moderna COVID vaccine safe, comparably effective in preschoolers ---clinical trial
Log in or register to post comments

The search for backup for key Covid therapy for immunocompromised people

Thu, 2022-10-20 11:25 — mike kraft

Biden officials search for backup for key Covid therapy for immunocompromised people Biden officials are bracing for the prospect that the sole preventive Covid treatment for immunocompromised people, Evusheld, could soon be ineffective. Sarah Owermohle STAT

...

Country / Region Tags:

General Topic Tags:

Disease Prevention

Problem, Solution, SitRep, or ?:

Situation Report

Read more about The search for backup for key Covid therapy for immunocompromised people
Log in or register to post comments

U.S. committee recommends that CDC add COVID shots to its free vaccine program

Wed, 2022-10-19 17:23 — mike kraft

U.S. committee recommends COVID shot for CDC's free vaccine program An expert committee on Wednesday recommended that COVID-19 shots become part of the U.S. Centers for Disease Control and Prevention's (CDC) vaccine program for children, which provides many types of free inoculations to millions of kids each year. Reuters Reuters

...

Country / Region Tags:

General Topic Tags:

Disease Prevention

Problem, Solution, SitRep, or ?:

Situation Report

Read more about U.S. committee recommends that CDC add COVID shots to its free vaccine program
Log in or register to post comments

U.S. FDA authorizes Novavax's COVID vaccine as booster for adults

Wed, 2022-10-19 12:32 — mike kraft

U.S. FDA authorizes Novavax's COVID vaccine as booster for adults The U.S. Food and Drug Administration on Wednesday authorized Novavax Inc's COVID-19 vaccine as a booster for adults, helping the company's shares reverse course and rise more than 3%. Reuters Reuters

...

Country / Region Tags:

General Topic Tags:

Disease Prevention

Problem, Solution, SitRep, or ?:

Situation Report

Read more about U.S. FDA authorizes Novavax's COVID vaccine as booster for adults
Log in or register to post comments

Opinion: Paxlovid coverage wrongly suggests the experts blew it again on Covid-19

Wed, 2022-10-19 10:21 — mike kraft

Opinion: Paxlovid coverage wrongly suggests the experts blew it again on Covid-19 | CNN The tone of reports about Paxlovid's interactions with other drugs is alarming, says Kent Sepkowitz. It seems to imply experts have exposed the world to another of their mistakes -- a view describing much of the criticism to the pandemic response. Kent Sepkowitz CNN

...

Country / Region Tags:

General Topic Tags:

Disease Prevention

Problem, Solution, SitRep, or ?:

Read more about Opinion: Paxlovid coverage wrongly suggests the experts blew it again on Covid-19
Log in or register to post comments

Analysis: U.S. Whites now more likely to die from covid than Blacks: Why the pandemic shifted

Wed, 2022-10-19 09:54 — mike kraft

Whites now more likely to die from covid than Blacks: Why the pandemic shifted As the pandemic progressed, the damage done by the coronavirus broadened, and the toxicity of modern-day politics came to the fore. Washington Post

...

Country / Region Tags:

General Topic Tags:

Disease Prevention

Public Attitudes

Social behavior

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Analysis: U.S. Whites now more likely to die from covid than Blacks: Why the pandemic shifted
Log in or register to post comments

Moderna says its Omicron booster response stays high through 3 months

Wed, 2022-10-19 09:34 — mike kraft

Moderna says Omicron booster response stays high through 3 months Moderna Inc said on Wednesday its COVID-19 vaccine booster targeting the BA.1 subvariant of Omicron generated a strong immune response against that variant, with antibody levels staying high for at least three months. Reuters Reuters

...

Country / Region Tags:

General Topic Tags:

Disease Prevention

Medical Testing

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Moderna says its Omicron booster response stays high through 3 months
Log in or register to post comments

Pages

Page loaded in 0.692 seconds.